You are here

  • Home
  • Archive
  • Volume 79, Issue 11
  • Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need to use CRP?’ by Gonçalves et al

Citation Tools

Article menu

Download PDFPDF

Correspondence response
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need to use CRP?’ by Gonçalves et al
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van Mens LJJ, van de Sande MGH, van Kuijk AWR, et al
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need to use CRP?’ by Gonçalves et al
Annals of the Rheumatic Diseases 2020;79:e143.